Clinical and genetic heterogeneity in Omenn syndrome and severe combined immune deficiency

Pediatric Transplantation

Volumn 13, Issue 2, 2009, Pages 244-250

  Gruber, Tanja A ^b   Shah, Ami J ^a,b   Hernandez, Michelle ^c   Crooks, Gay M ^a,b   Abdel Azim, Hisham ^a,b   Gupta, Sudhir ^d   McKnight, Sean ^e   White, Drew ^c   Kapoor, Neena ^a,b   Kohn, Donald B ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

Common gamma chain; Omenn syndrome; RAG1; Severe combined immune deficiency

Indexed keywords

ANTIBIOTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYTOKINE RECEPTOR; FLUDARABINE; IMMUNOGLOBULIN G; RECOMBINASE; RITUXIMAB; THYMOCYTE ANTIBODY;

ACID FAST BACTERIUM; ADD ON THERAPY; ARTICLE; ATOPIC DERMATITIS; B LYMPHOCYTE; BLOOD ANALYSIS; BLOOD GROUP TYPING; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; BRONCHOSCOPY; CASE REPORT; CHRONIC DIARRHEA; CLOSTRIDIUM DIFFICILE; COLONOSCOPY; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; COUGHING; DEHYDRATION; DNA DETERMINATION; EOSINOPHIL COUNT; ERYTHEMA; ERYTHRODERMA; FECES CULTURE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENETIC HETEROGENEITY; HLA SYSTEM; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNIZATION; IMMUNOLOGICAL PROCEDURES; INFANT; INFLAMMATION; LEUKOCYTE COUNT; LIVER SIZE; LUNG ALVEOLUS MACROPHAGE; LUNG INFILTRATE; LUNG LAVAGE; LYMPHOCYTE COUNT; MALE; NATURAL KILLER CELL; NEWBORN; OMENN SYNDROME; OTITIS MEDIA; PATHOGENESIS; PHENOTYPE; PNEUMONIA; RASH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEVERE COMBINED IMMUNODEFICIENCY; SPLEEN SIZE; STAINING; T LYMPHOCYTE; THORAX RADIOGRAPHY; THRUSH; WHEEZING;

CYTOKINES; EXANTHEMA; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; MALE; MODELS, GENETIC; MUTATION; PHENOTYPE; SEVERE COMBINED IMMUNODEFICIENCY; T-LYMPHOCYTES; TIME FACTORS; TREATMENT OUTCOME; VDJ RECOMBINASES;

EID: 59449106399     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2008.00970.x     Document Type: Article

References (18)

1. Omenn GS. Familial reticuloendotheliosis with eosinophilia. N Engl J Med 1965 : 273 : 427 432.
2. Villa A, Santagata S, Bozzi F, et al. Partial V(D)J recombination activity leads to Omenn syndrome. Cell 1998 : 93 : 885 896.
3. c-chain defects causing human X-SCID. Immunol Today 1996 : 17 : 507 511.
4. Gennery AR, Hodges E, Williams AP, et al. Omenn's syndrome occurring in patients without mutations in recombination activating genes. Clin Immunol 2005 : 116 : 246 256.
5. Cavadini P, Vermi W, Facchetti F, et al. AIRE deficiency in thymus of 2 patients with Omenn syndrome. J Clin Invest 2005 : 115 : 728 732.
6. Giliani S, Bonfim C, de Saint Basile G, et al. Omenn syndrome in an infant with IL7RA gene mutation. J Pediatr 2006 : 148 : 272 274.
7. Roifman CM, Gu Y, Cohen A. Mutations in the RNA component of RNase mitochondrial RNA processing might cause Omenn syndrome. J Allergy Clin Immunol 2006 : 117 : 897 903.
8. Ege M, Ma Y, Manfras B, et al. Omenn syndrome due to ARTEMIS mutations. Blood 2005 : 105 : 4179 4186.
9. Corneo B, Moshous D, Gungor T, et al. Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome. Blood 2001 : 97 : 2772 2776.
10. Villa A, Sobacchi C, Notarangelo LD, et al. V(D)J recombination defects in lymphocytes due to RAG mutations: Severe immunodeficiency with a spectrum of clinical presentations. Blood 2001 : 97 : 81 88.
11. Santagata S, Gomez CA, Sobacchi C, et al. N-terminal RAG1 frameshift mutations in Omenn's syndrome: Internal methionine usage leads to partial V(D)J recombination activity and reveals a fundamental role in vivo for the N-terminal domains. Proc Natl Acad Sci U S A 2000 : 97 : 14572 14577.
12. Puck JM, Pepper AE, Henthorn PS, et al. Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. Blood 1997 : 89 : 1968 1977.
13. Ehl S, Schwarz K, Enders A, et al. A variant of SCID with specific immune responses and predominance of γδT cells. J Clin Invest 2005 : 115 : 3140 3148.
14. deVillartay JP, Lim A, Al-Mousa H, et al. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J Clin Invest 2005 : 115 : 3291 3299.
15. Dalal I, Tabori U, Bielorai B, et al. Evolution of a T-B-SCID into an Omenn syndrome phenotype following parainfluenza 3 virus infection. Clin Immunol 2005 : 115 : 70 73.
16. Wada T, Toma T, Okamoto H, et al. Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immune deficiency. Blood 2005 : 106 : 2099 2101.
17. Noordzij JG, Verkaik NS, Hartwig NG, de Groot R, van Gent DC, van Dongen JM. N-terminal truncated human RAG1 proteins can direct T-cell receptor but not immunoglobulin gene rearrangements. Blood 2000 : 96 : 203 209.
18. Schwarz K, Gauss GH, Ludwig L, et al. RAG mutations in human B cell-negative SCID. Science 1996 : 274 : 97 99.